Clinical Trials Directory

Trials / Completed

CompletedNCT03743519

The Efficacy of a Tart Cherry Drink for the Treatment of Patellofemoral Pain in Recreational Athletes.

The Efficacy of a Tart Cherry Drink for Patellofemoral Pain.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
24 (actual)
Sponsor
University of Central Lancashire · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Patellofemoral pain (PFP) is the most common chronic pathology in sports medicine and physiotherapy clinics. As pain and inflammation are the main symptoms of PFP, non-steroidal anti-inflammatory and analgesic medications are often utilized to decrease pain and inflammation; however alternative treatments are increasingly being sought due to the cardiovascular and gastrointestinal side effects of traditional pain medications. Most researchers advocate conservative treatment, though there is still insufficient clarity regarding the effectiveness of conservative treatment modalities. Dietary interventions for PFP have not received any attention in clinical literature, yet there is a growing body of evidence indicating that cherries have significant anti-inflammatory, antioxidant and pain-mediating effects. Therefore, the primary purpose of the proposed investigation was to test (using a randomized control investigation) the ability of a tart cherry juice blend to provide symptom relief in recreational athletes with PFP and to understand the biological and mechanical mechanisms behind any changes in PFP symptoms.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTCherry juice30 mL of tart cherry juice concentrate, which will be diluted with 200 mL of water.
DIETARY_SUPPLEMENTPlaceboIdentical in taste and colour to the Cherry juice, but with no anthocyanin content

Timeline

Start date
2019-05-30
Primary completion
2020-05-30
Completion
2020-06-01
First posted
2018-11-16
Last updated
2020-07-21

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT03743519. Inclusion in this directory is not an endorsement.